FDA Adverse Event Malfunction Summary report: N

SYRINGE S2 20ML

MDR report key: 10460725 · Received August 27, 2020

Report

Report Number
3002682307-2020-00261
Event Type
Malfunction
Date Received
August 27, 2020
Date of Event
August 6, 2020
Report Date
September 17, 2020
Manufacturer
BECTON DICKINSON, S.A.
Product Code
FMF
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D.10. DEVICE AVAILABLE FOR EVAL?: YES. D.10. RETURNED TO MANUFACTURER ON: 9/2/2020. H.6. INVESTIGATION: A DEVICE HISTORY RECORD REVIEW WAS PERFORMED FOR PROVIDED LOT NUMBER 2002112 AND THE REVIEW DID NOT REVEAL ANY DETECTED QUALITY ISSUES DURING THE PRODUCTION PROCESS THAT COULD HAVE CONTRIBUTED TO THIS REPORTED INCIDENT. TO AID IN THE INVESTIGATION OF THIS ISSUE, BOTH PICTURE AND PHYSICAL SAMPLES WERE RETURNED FOR EVALUATION BY OUR QUALITY ENGINEER TEAM. THROUGH EXAMINATION OF THE SAMPLES, WHITE PARTICLES WERE OBSERVED WITHIN THE SYRINGE. THE WHITE PARTICLES WERE IDENTIFIED AS LUBRICANT FROM THE SYRINGE BARREL. THIS LUBRICANT IS INCLUDED IN THE PLASTIC FORMULATION AND IS INHERENT TO THE DESIGN AND FUNCTION OF THE TWO PIECE SYRINGE. THE NORMAL FUNCTIONALITY OF THE SYRINGE WOULD NOT WORK WITHOUT THE PRESENCE OF THIS LUBRICANT. DURING THE MANUFACTURING PROCESS, THE LUBRICANT FORMS A MICROSCOPIC LAYER IN THE INTERNAL AND EXTERNAL WALLS OF THE BARREL. WHEN THE PLUNGER IS MOVED BACKWARDS DURING THE FILLING OF THE SYRINGE, MOST OF THIS MICROSCOPIC LAYER OF LUBRICANT IS DRAGGED BEHIND THE PLUNGER AND A SMALL QUANTITY STILL REMAINS INSIDE TO ALLOW A GOOD SLIDING PERFORMANCE DURING THE INJECTION PROCESS. THE MOST RESTRICTIVE REGULATIONS FROM DIFFERENT COUNTRIES SPECIFY THE MAXIMUM AMOUNT OF LUBRICANT AND THE TWO-PIECE BD SYRINGE IS BELOW THAT LIMIT. TOXICOLOGICAL TESTING OF THE SLIP AGENT HAS INDICATED AN EXTREMELY LOW TO NEGLIGIBLE RISK FOR THE APPLICATION OF THIS PRODUCT.

Description of Event or Problem · 0

IT WAS REPORTED THAT SYRINGE S2 20ML HAD FOREIGN MATTER INSIDE OF THE SYRINGE. THIS WAS DISCOVERED DURING USE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: REPORTING OF LOOSE PIECES OF PLASTIC IN THE DISCARDIT 20ML SYRINGES. THE PLASTIC IS ACTUALLY BEING INJECTED INTO THE HORSES WHEN BEING USED. -DATE WHEN THE LOOSE PLASTIC PIECES WERE NOTICED? SOMETIME LAST WEEK. -WHERE DID THE PROBLEM OCCUR? REMOVED THE PLUNGER TO ADD SEMEN AND NOTICED THE LOOSE PIECES. -IN HOW MANY SYRINGES? AT LEAST 10 SYRINGES THEN USED SYRINGES OUT OF MY CAR OF ANOTHER BATCH. -HOW MANY HORSES WERE AFFECTED? HARD TO SAY SINCE WE DON¿T ALWAYS REMOVE THE PLUNGER SOME VETS ASPIRATE THE SEMEN INTO THE SYRINGE AND SINCE SEMEN/SEMEN EXTENDER IS WHITE YOU WOULD NOT NOTICE IT.

Additional Manufacturer Narrative · 1

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT SYRINGE S2 20ML HAD FOREIGN MATTER INSIDE OF THE SYRINGE. THIS WAS DISCOVERED DURING USE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: REPORTING OF LOOSE PIECES OF PLASTIC IN THE DISCARDIT 20ML SYRINGES. THE PLASTIC IS ACTUALLY BEING INJECTED INTO THE HORSES WHEN BEING USED. -DATE WHEN THE LOOSE PLASTIC PIECES WERE NOTICED? SOMETIME LAST WEEK. -WHERE DID THE PROBLEM OCCUR? REMOVED THE PLUNGER TO ADD SEMEN AND NOTICED THE LOOSE PIECES. -IN HOW MANY SYRINGES? AT LEAST 10 SYRINGES THEN USED SYRINGES OUT OF MY CAR OF ANOTHER BATCH. -HOW MANY HORSES WERE AFFECTED? HARD TO SAY SINCE WE DON¿T ALWAYS REMOVE THE PLUNGER SOME VETS ASPIRATE THE SEMEN INTO THE SYRINGE AND SINCE SEMEN/SEMEN EXTENDER IS WHITE YOU WOULD NOT NOTICE IT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
928136 SYRINGE S2 20ML SYRINGE FMF BECTON DICKINSON, S.A. 2002112

Patients

Seq Age Sex Outcome Treatment
1 Other